These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3680556)

  • 1. Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide.
    Pulkkinen MO
    J Clin Pharmacol; 1987 Jan; 27(1):65-9. PubMed ID: 3680556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimesulide in dysmenorrhoea.
    Pulkkinen M
    Drugs; 1993; 46 Suppl 1():129-33. PubMed ID: 7506151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
    Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women.
    Pulkkinen MO; Csapo AI
    Prostaglandins; 1979 Jul; 18(1):137-42. PubMed ID: 392621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
    Pirhonen J; Pulkkinen M
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
    Hauksson A; Akerlund M; Forsling ML; Kindahl H
    J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of exogenous intrauterine progesterone on the amount and prostaglandin F2alpha content of menstrual blood in dysmenorrheic women.
    Trobough G; Guderian AM; Erickson RR; Tillson SA; Leong P; Swisher DA; Pharriss BB
    J Reprod Med; 1978 Sep; 21(3):153-8. PubMed ID: 722696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide.
    Pulkkinen M; Monti T; Macciocchi A
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):181-5. PubMed ID: 1317639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized, double-blinded, placebo-controlled crossover study.
    Iacovides S; Baker FC; Avidon I
    Arch Gynecol Obstet; 2014 May; 289(5):993-1002. PubMed ID: 24190696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
    López Rosales C; Cisneros Lugo JH; Romo Enciso LJ; García Sandoval MG
    Ginecol Obstet Mex; 1989 Jul; 57():196-201. PubMed ID: 2486951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY; Fuchs F; Powell AM
    Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prostaglandin F 2-alpha levels in dysmenorrehic women.
    Shangold MM; Aksel S; Schomberg DW; Hammond CB
    Fertil Steril; 1976 Oct; 27(10):1171-5. PubMed ID: 971774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid.
    Chan WY; Dawood MY; Fuchs F
    Am J Obstet Gynecol; 1979 Sep; 135(1):102-8. PubMed ID: 474640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimesulide in the treatment of menstrual migraine.
    Giacovazzo M; Gallo MF; Guidi V; Rico R; Scaricabarozzi I
    Drugs; 1993; 46 Suppl 1():140-1. PubMed ID: 7506154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to the pathogenesis of dysmenorrhea.
    Zahradnik HP; Breckwoldt M
    Arch Gynecol; 1984; 236(2):99-108. PubMed ID: 6596911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea.
    Dawood MY
    Am J Med; 1988 May; 84(5A):23-9. PubMed ID: 3287908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects.
    Chan WY; Hill JC
    Prostaglandins; 1978 Feb; 15(2):365-75. PubMed ID: 635225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Menstrual prostaglandin and dysmenorrhea: modulation by non-steroidal antiinflammatory drugs].
    Di Girolamo G; Gimeno MA; Faletti A; de los Santos AR; Martí ML; Zmijanovich R
    Medicina (B Aires); 1999; 59(3):259-64. PubMed ID: 10451565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.